UC AKT.ANL. 12/24 SRT3/ DE000HD1QQ39 /
14/05/2024 11:45:58 | Chg.+1.930 | Bid12:59:46 | Ask12:59:46 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
93.640EUR | +2.10% | - Bid Size: 125,000 |
- Ask Size: 125,000 |
SARTORIUS AG VZO O.N... | 315.00 - | 31/12/2024 | Call |
GlobeNewswire
13:00
BioCryst to Present New Data at 2024 Meeting of the European Academy of Allergy and Clinical Immunol...
GlobeNewswire
13:00
Breckenridge Brewery Announces On Tap with KBCO Concert Series Featuring Cannons, The Moss and Dehd
GlobeNewswire
13:00
InspireMD Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
13:00
Inotiv, Inc. to Report Fiscal 2024 Second Quarter Financial Results and Host Conference Call on Wedn...
GlobeNewswire
13:00
Troilus Announces Feasibility Study Results for the Gold-Copper Troilus Project: Outlines a Large Sc...
GlobeNewswire
13:00
ElevateBio Announces New U.S. Patents for Lead Life Edit CRISPR Systems and Adenine Deaminases Enabl...
GlobeNewswire
13:00
One in four US subscribers will sign up to a new streaming service to watch the Olympics
GlobeNewswire
13:00
MetaWorks' New Venture, Energy Works, Inc., to Revolutionize Plastic Waste Management with Cutting-E...
GlobeNewswire
13:00
Bitfarms Doubles Yguazu Power Capacity to 200 MW with Additional 100 MW of Hydropower in Paraguay
GlobeNewswire
13:00
Hotel Equities Selected to Manage First Hampton by Hilton-Branded Hotel in St. Thomas, U.S. Virgin I...
GlobeNewswire
13:00
Optinose Reports First Quarter 2024 Financial Results and Recent Operational Highlights
GlobeNewswire
13:00
POET Announces Design Win and Collaboration with Foxconn Interconnect Technology for High-speed AI S...
GlobeNewswire
13:00
Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros Pha...